Navigation Links
Neuro-Biotech's Solution for a Doctor near You: Early Detection for Alzheimer's and Chronic Fatigue Syndrome!
Date:9/20/2010

BASEL, Switzerland, Sept. 20 /PRNewswire-FirstCall/ - Neuro-Biotech Corporation (PINKSHEETS: MRES) (OTCQB: MRES) is a worldwide based biotechnological enterprise involved in the unique international niche of clinical neuroscience diagnostic testing. Neuro-Biotech's presently has the opportunity to market 12 clinical "Neuro Blood Tests" through partnerships. Neuro-Biotech's proprietary diagnostic tests are without equal in being rapidly done as an essential complement to current clinical laboratory testing procedures, by being non-invasive, sensitive, and reliable. This will provide general practitioners and specialists alike, useful medical parameters in the analysis and treatment of workplace stress-related diseases and mental-health disorders, such as Alzheimer's.

As a result of more than 20 years of research and development (R&D), Neuro-Biotech Corp.'s specific expertise is the understanding of the communication between the brain and the human body and their various influences on the peripheral systems, in order to maintain the internal equilibrium of a person's state of mind.

This exclusive understanding of the relationships between the neurotransmitter families within the brain led to the development of a portfolio of in vitro diagnostic blood tests. They will be used for the detection, prevention, monitoring and follow-up of the major psycho-social environmental diseases. They can be stress-related, socio-professional and occupational diseases, such as Chronic Fatigue Syndrome (CFS), Great Anxiety (GA), Panic Syndrome (PS); Cardiovascular diseases like Essential Hypertension or Arrhythmia; Neurodegenerative diseases such as Alzheimer or Parkinson's Disease as well as Mental-Health Disorders in the vein of Depression and Schizophrenia

Caregivers can now evaluate and establish an individual's ability to react to stress by monitoring bio-indicators within the blood or other biological fluids. Efficient and improved patient supervision, treatment and follow-up care can be instituted.

Clinical Neuroscience-related diseases can be difficult to diagnose and complex to treat. If we don't know the full state of health of an individual and the progression of the therapy... How can we truly manage the care and rehabilitation? Neuro-Biotech Corp. has the solution!


'/>"/>
SOURCE Neuro-Biotech Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Safran Enters Into a Definitive Agreement With L-1 Identity Solutions for the Purchase of L-1 Biometrics and ID Management Solutions Businesses
2. Marrone Bio Innovations to Present Invasive Mussel Control Solution
3. Applied Precision Installs New DeltaVision
4. OMX® Super-Resolution Imaging System in the Light Microscopy Imaging Center at Indiana University
5. Scientists achieve highest-resolution MRI of a magnet
6. Dyadic International Announces Final Resolution and Dismissal of Stockholder Class Action Lawsuit
7. Pfizer Wins CIO 100 Award for Patient Enrollment Optimization Solution From DecisionView
8. BioSpec Global Solutions Inc. Enters into talks with possible Chinese partner
9. Case Western Reserve University-led team takes high resolution photo of a K+ channel
10. Promega Now Offers Complete Solution for Profiling Kinase Inhibitor Compounds Against the Human Kinome
11. Haydon Kerk Motion Solutions Introduces the RGS04 Dual Carriage Linear Rail and Programmable Actuator Assembly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking ... Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity as ...
(Date:6/23/2016)... 23, 2016 On Wednesday, June 22, ... down 0.22%; the Dow Jones Industrial Average edged 0.27% lower ... 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the following ... Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing ...
(Date:6/23/2016)... , June 23, 2016 ... market research report to its pharmaceuticals section with ... product details and much more. Complete ... across 151 pages, profiling 15 companies and supported ... at http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The ...
Breaking Biology Technology:
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/15/2016)... -- A new partnership announced today will help life ... a fraction of the time it takes today, ... insurance policies to consumers without requiring inconvenient and ... rapid testing (A1C, Cotinine and HIV) and higi,s ... pulse, BMI, and activity data) available at local ...
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
Breaking Biology News(10 mins):